MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by University of Michigan
Sponsor:
Information provided by (Responsible Party):
Vanessa K. Dalton, University of Michigan
ClinicalTrials.gov Identifier:
NCT01769560
First received: January 14, 2013
Last updated: March 26, 2013
Last verified: March 2013
  Purpose

This study will test whether a tailored, online educational intervention increases HPV vaccine uptake and intent among female college students.


Condition Intervention
HPV
Behavioral: MeFirst Tailored Intervention

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Health Services Research
Official Title: MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

Further study details as provided by University of Michigan:

Primary Outcome Measures:
  • Determine the effect of Me First, a tailored, online HPV vaccination decision-making guide on HPV vaccination intention and/or uptake. [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Determine the effect of Me First on HPV-related knowledge. [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Other Outcome Measures:
  • Determine acceptability of the Me First tool to participants immediately post-test. [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 2000
Study Start Date: January 2013
Estimated Study Completion Date: April 2014
Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: CDC Fact Sheet
Participants will receive the CDC Fact sheet about HPV vaccination while they are taking the survey.
Behavioral: MeFirst Tailored Intervention
Participants will be lead through an interactive web-based tool that is tailored to their responses during the survey. This tool provides information regarding HPV Vaccination.

Detailed Description:

Me First is the first web-based, online, educational tool designed to promote Human Papillomavirus (HPV) vaccine awareness and understanding in an effort to improve HPV vaccine intent and uptake among female university students. HPV is the most common sexually transmitted infection and causes genital warts and cancer. The HPV vaccine has been recommended for girls ages 11-26 since 2006, yet vaccination rates remain low. Tailored online interventions may be more effective tools to promote behavior change among college students than traditional static interventions. The proposed study is a randomized controlled trial testing the efficacy of the Me First tool vs. standard static educational material on increasing HPV vaccination intent and uptake among female university students aged 18-26.

  Eligibility

Ages Eligible for Study:   18 Years to 26 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • enrolled at the University of Michigan

Exclusion Criteria:

  • receipt of any doses of HPV vaccine
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01769560

Contacts
Contact: Melissa K Zochowski, MBA 734-930-5622 mzochows@med.umich.edu
Contact: Vanessa Dalton, MD, MPH 734-930-5611 daltonvk@med.umich.edu

Locations
United States, Michigan
Univeristy of Michigan Recruiting
Ann Arbor, Michigan, United States, 48106
Contact       PWHERStudies@umich.edu   
Principal Investigator: Vanessa K Dalton, MD, MPH         
Sponsors and Collaborators
University of Michigan
  More Information

No publications provided

Responsible Party: Vanessa K. Dalton, Associate Professor, University of Michigan
ClinicalTrials.gov Identifier: NCT01769560     History of Changes
Other Study ID Numbers: HUM00069032
Study First Received: January 14, 2013
Last Updated: March 26, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Michigan:
tailored intervention
college aged students
HPV

ClinicalTrials.gov processed this record on July 20, 2014